SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, is FDA-pending for clinical use in the United States. "We are thrilled to receive 510(k) pending status for SyMRI 3D,” says Ulrik Harrysson, CEO at SyntheticMR AB. “SyMRI 3D represents a pivotal leap forward in medical imaging, offering new possibilities for diagnosis and treatment.” SyMRI 3D is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within SyMRI's post-processing solution. SyMRI 3D enables precise